To include your compound in the COVID-19 Resource Center, submit it here.

Trump drug pricing remarks blunt biopharmas' gains

Biopharma stocks gave back early intraday gains on Monday after President Trump reiterated his intention to address prescription drug prices. In remarks during a cabinet meeting, Trump said

Read the full 287 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE